期刊文献+

新型左旋棉酚纳米微球的制备及性质研究 被引量:1

Studies of the preparation and properties of new nanoparticles of(-)-gossypol
下载PDF
导出
摘要 目的:以mPEG-mal(单甲氧基聚乙二醇-马来酰亚胺)为原料,制备负载左旋棉酚的高分子纳米微球,并全面考察其性质。方法:通过O/W乳化扩散/挥发法,制备负载左旋棉酚的纳米粒子,优化制备工艺并考察纳米粒子的形态、粒径分布、体外释药特性及稳定性等性质。结果:通过乳剂-挥发法制备的空白粒子呈规整的球形,载药粒子的粒径为(65.1±15.2)nm,左旋棉酚的平均载药量为(37.5±0.3)%。体外释放实验显示,载药粒子具有缓释特征,在12h、24h、10d分别释放7.2%、14.6%、87.7%,并且稳定性良好。结论:本研究制备的左旋纳米微球具有一定的缓释特征,具有良好的应用前景和价值。 Objective:To prepare(-)-gossypol-loaded nanoparticles with mPEG-maleimide,and evaluate their properties.Methods: The nanoparticles were prepared by O/W emulsion-evaporation method.Optimize the preparation technology.The physical properties of nanoparticles such as morphology,particle size,drug release,storage stability were studied comprehensively.Results: The blank nanoparticles were regular global shape.The diameter of(-)-gossypol loaded nanoparticles was(65.1±15.2) nm.The average drug loading content was(37.5 ±0.3)%.In vitro release study demonstrated the sustained release of(-)gossypol from(-)gossypol-loaded nanoparticles with the release of 7.2%,14.6% and 87.7% percentage of total drug at 12h,24h,and 10d,respectively.(-)-Gossypol loaded nanoparticles have good storage stability.Conclusion:(-)-Gossypol-loaded nanoparticles reported in the current report showed a good sustained release property,which featured it a potential application in cancer treatment.
出处 《现代肿瘤医学》 CAS 2012年第2期269-272,共4页 Journal of Modern Oncology
关键词 左旋棉酚 纳米粒子 药物输送体系 乳化-挥发法 (-)-gossypol nanoparticles drug-delivery system emulsion-evaporation method
  • 相关文献

参考文献2

二级参考文献43

  • 1Zhang M, Liu H, Guo R, Ling Y, Wu X, et al. Molecular mechanism of gossypol-induced cell growth inhibition and cell death of HT-29 human colon carcinoma cells. Biochem Pharmacol 2003; 66: 93-103.
  • 2Jiang J, Sugimoto Y, Liu S, Chang HL, Park KY, et aL The inhibitory effects of gossypol on human prostate cancer cells-PC3 are associated with transforming growth factor betal (TGFβ1) signal transduction pathway. Anticancer Res 2004; 24: 91-100.
  • 3Ligueros M, Jeoung D, Tang B, Hochhauser D, Reidenberg MM, et al. Gossypol inhibition of mitosis, cyclin DI and Rb protein in human mammary cancer cells and cyclin-D1 transfected human fibrosarcoma cells. Br J Cancer 1997; 76: 21-8.
  • 4Macoska JA, Adsule S, Tantivejkul K, Wang S, Pienta K J, et al. (-)-Gossypol promotes the apoptosis of bladder cancer cells in vitro. Pharmacol Res 2008; 58:323-31.
  • 5Mohammad RM, Wang S, Banerjee S, Wu X, Chen J, et al. Nonpeptidic small-molecule inhibitor of Bcl-2 and BcI-XL, (-)-Gossypol, enhances biological effect of genistein against BxPC-3 human pancreatic cancer cell line. Pancreas 2005; 31: 317-24.
  • 6Kilic A, Schuchert MJ, Luketich JD, Landreneau R J, El- Hefnawy T. Efficacy of signal pathway inhibitors alone and in combination with Cisplatin varies between human non- small cell lung cancer lines. J Surg Res 2009; 154: 9-12.
  • 7Huang YW, Wang LS, Chang HL, Ye W, Dowd MK, et al. Molecular mechanisms of (-)-gossypol-induced apoptosis in human prostate cancer cells. Anticancer Res 2006; 26: 1925-33.
  • 8Wolter KG, Wang S J, Henson BS, Wang S, Griffith KA, et al. (-)-Gossypol inhibits growth and promotes apoptosis of human head and neck squamous cell carcinoma in vivo. Neoplasia 2006; 8: 163-72.
  • 9Bauer JA, Trask DK, Kumar B, Los G, Castro J, et al. Reversal of cisplatin resistance with a BH3 mimetic, (-)-gossypol, in head and neck cancer cells: role of wild-type p53 and Bcl-xL. Mol Cancer Ther 2005; 4: 1096-104.
  • 10Shelley MD, Hartley L, Fish RG, Groundwater P, Morgan JJ, et al. Stereo-specific cytotoxic effects of gossypol enantiomers and gossypolone in tumour cell lines. Cancer Lett 1999; 135: 171-80.

共引文献3

同被引文献22

  • 1贾光锋.棉酚及其衍生物的抗肿瘤效果和生产工艺的研究进展[J].食品与药品,2007,9(09A):53-56. 被引量:2
  • 2KESHMIRI-NEGHAB H, GOLIAEI B. Therapeutic potential of gossypol: an overview [J].Pharm Biol, 2014, 52(1): 124- 128.
  • 3MENG Y, TANG W, DAI Y, et al. Natural BH3 mimetic ( - )- gossypol ehemosensitizes human prostate cancer via Bcl-xL inhi- bition accompanied by increase of Puma and Noxa ~ J ]. Mol Cancer Ther, 2008, 7 ( 7 ) : 2192 - 2202.
  • 4WAGNER TA, LIU J, STIPANOVIC RD, et al. Hemigossypol, a constituent in developing glanded cottonseed ( Gossypium hirsu- tum) [ J]. J Agric Food Chem, 2012, 60(10): 2594-2598.
  • 5WEI J, VANDER JAGT DL, ROYER RE, et al. Synthesis of hemigossypol and its derivatives [ J ]. Tetrahedron Lett, 2010, 51(44) : 5757 -5760.
  • 6LI L, LIU Y, WANG Q. Regioseleetive oxidative dehydrogena- tion under nonenzymatie conditions: a synthetic route to gossypol [J]. Eur J Org Chem, 2013, 35(12): 8014 -8021.
  • 7厉保秋.一种醋酸棉酚静脉注射脂肪乳剂的制备方法:中国,CNl01829053A[P].2010-5-6.
  • 8吴道澄,李科,刘佳俊,等.自组装法制备棉酚及其衍生物普朗尼克纳米粒子的方法:中国,CNl04523606A[P].2014-11-20.
  • 9OKOAMPAH A, TANG L. The effect of incorporating gossypol into L-ascorbyl palmitate coagel on theological and viscoelastic properties [J]. LatAnt JPharm, 2015, 34(3): 576-584.
  • 10HELEGSHABTAI V, AIZEN R, ORBACH R, et al. Gossypol- cross-linked boronic acid-modified hydrogels: a functional matrix for the controlled release of art anticancer drug [ J ]. Lartgmuir, 2015, 31(7) : 2237 -2242.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部